Signals to promote myelin formation and repair

Carla Taveggia, Maria Laura Feltri, Lawrence Wrabetz

Research output: Contribution to journalArticle

177 Citations (Scopus)

Abstract

The myelin sheath wraps large axons in both the CNS and the PNS, and is a key determinant of efficient axonal function and health. Myelin is targeted in a series of diseases, notably multiple sclerosis (MS). In MS, demyelination is associated with progressive axonal damage, which determines the level of patient disability. The few treatments that are available for combating myelin damage in MS and related disorders, which largely comprise anti-inflammatory drugs, only show limited efficacy in subsets of patients. More-effective treatment of myelin disorders will probably be accomplished by early intervention with combinatorial therapies that target inflammation and other processesfor example, signaling pathways that promote remyelination. Indeed, evidence suggests that such pathways might be impaired in pathology and, hence, contribute to the failure of remyelination in such diseases. In this article, we review the molecular basis of signaling pathways that regulate myelination in the CNS and PNS, with a focus on signals that affect differentiation of myelinating glia. We also discuss factors such as extracellular molecules that act as modulators of these pathways. Finally, we consider the few preclinical and clinical trials of agents that augment this signaling.

Original languageEnglish
Pages (from-to)276-287
Number of pages12
JournalNature Reviews Neurology
Volume6
Issue number5
DOIs
Publication statusPublished - May 2010

Fingerprint

Myelin Sheath
Multiple Sclerosis
Demyelinating Diseases
Neuroglia
Axons
Anti-Inflammatory Agents
Therapeutics
Clinical Trials
Pathology
Inflammation
Health
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Signals to promote myelin formation and repair. / Taveggia, Carla; Feltri, Maria Laura; Wrabetz, Lawrence.

In: Nature Reviews Neurology, Vol. 6, No. 5, 05.2010, p. 276-287.

Research output: Contribution to journalArticle

Taveggia, Carla ; Feltri, Maria Laura ; Wrabetz, Lawrence. / Signals to promote myelin formation and repair. In: Nature Reviews Neurology. 2010 ; Vol. 6, No. 5. pp. 276-287.
@article{9cd4f7d433ee40579ddce9dcce00ddb3,
title = "Signals to promote myelin formation and repair",
abstract = "The myelin sheath wraps large axons in both the CNS and the PNS, and is a key determinant of efficient axonal function and health. Myelin is targeted in a series of diseases, notably multiple sclerosis (MS). In MS, demyelination is associated with progressive axonal damage, which determines the level of patient disability. The few treatments that are available for combating myelin damage in MS and related disorders, which largely comprise anti-inflammatory drugs, only show limited efficacy in subsets of patients. More-effective treatment of myelin disorders will probably be accomplished by early intervention with combinatorial therapies that target inflammation and other processesfor example, signaling pathways that promote remyelination. Indeed, evidence suggests that such pathways might be impaired in pathology and, hence, contribute to the failure of remyelination in such diseases. In this article, we review the molecular basis of signaling pathways that regulate myelination in the CNS and PNS, with a focus on signals that affect differentiation of myelinating glia. We also discuss factors such as extracellular molecules that act as modulators of these pathways. Finally, we consider the few preclinical and clinical trials of agents that augment this signaling.",
author = "Carla Taveggia and Feltri, {Maria Laura} and Lawrence Wrabetz",
year = "2010",
month = "5",
doi = "10.1038/nrneurol.2010.37",
language = "English",
volume = "6",
pages = "276--287",
journal = "Nature Reviews Neurology",
issn = "1759-4758",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Signals to promote myelin formation and repair

AU - Taveggia, Carla

AU - Feltri, Maria Laura

AU - Wrabetz, Lawrence

PY - 2010/5

Y1 - 2010/5

N2 - The myelin sheath wraps large axons in both the CNS and the PNS, and is a key determinant of efficient axonal function and health. Myelin is targeted in a series of diseases, notably multiple sclerosis (MS). In MS, demyelination is associated with progressive axonal damage, which determines the level of patient disability. The few treatments that are available for combating myelin damage in MS and related disorders, which largely comprise anti-inflammatory drugs, only show limited efficacy in subsets of patients. More-effective treatment of myelin disorders will probably be accomplished by early intervention with combinatorial therapies that target inflammation and other processesfor example, signaling pathways that promote remyelination. Indeed, evidence suggests that such pathways might be impaired in pathology and, hence, contribute to the failure of remyelination in such diseases. In this article, we review the molecular basis of signaling pathways that regulate myelination in the CNS and PNS, with a focus on signals that affect differentiation of myelinating glia. We also discuss factors such as extracellular molecules that act as modulators of these pathways. Finally, we consider the few preclinical and clinical trials of agents that augment this signaling.

AB - The myelin sheath wraps large axons in both the CNS and the PNS, and is a key determinant of efficient axonal function and health. Myelin is targeted in a series of diseases, notably multiple sclerosis (MS). In MS, demyelination is associated with progressive axonal damage, which determines the level of patient disability. The few treatments that are available for combating myelin damage in MS and related disorders, which largely comprise anti-inflammatory drugs, only show limited efficacy in subsets of patients. More-effective treatment of myelin disorders will probably be accomplished by early intervention with combinatorial therapies that target inflammation and other processesfor example, signaling pathways that promote remyelination. Indeed, evidence suggests that such pathways might be impaired in pathology and, hence, contribute to the failure of remyelination in such diseases. In this article, we review the molecular basis of signaling pathways that regulate myelination in the CNS and PNS, with a focus on signals that affect differentiation of myelinating glia. We also discuss factors such as extracellular molecules that act as modulators of these pathways. Finally, we consider the few preclinical and clinical trials of agents that augment this signaling.

UR - http://www.scopus.com/inward/record.url?scp=77952242933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952242933&partnerID=8YFLogxK

U2 - 10.1038/nrneurol.2010.37

DO - 10.1038/nrneurol.2010.37

M3 - Article

C2 - 20404842

AN - SCOPUS:77952242933

VL - 6

SP - 276

EP - 287

JO - Nature Reviews Neurology

JF - Nature Reviews Neurology

SN - 1759-4758

IS - 5

ER -